International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks.

IF 3.4 2区医学 Q2 PHARMACOLOGY & PHARMACY

Drug Metabolism Reviews Pub Date : 2021-05-01 Epub Date: 2021-04-09 DOI:10.1080/03602532.2021.1910293

Mary A Schleiff, Jasleen K Sodhi

引用次数: 1

Abstract

The International Society for the Study of Xenobiotics (ISSX) New Investigators Group has assembled a global team of emerging scientists to collaboratively compose a series of articles whose topics span the broad field of drug metabolism and will guide both new and established investigators alike. The New Investigator Group Committee members are proud to have provided such an opportunity to many promising early-career scientists from across the globe, and would like to acknowledge each contributor for their efforts.

查看原文本刊更多论文

国际异种生物研究学会(ISSX)新研究者小组委员会2019-2020结论性发言。

国际异种生物研究学会(ISSX)新研究小组已经组建了一个由新兴科学家组成的全球团队，共同撰写一系列文章，其主题涵盖药物代谢的广泛领域，并将指导新的和现有的研究人员。新研究小组委员会的成员很自豪能够为来自世界各地的许多有前途的早期职业科学家提供这样的机会，并感谢每位贡献者的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug Metabolism Reviews 医学-药学

CiteScore

11.10

自引率

1.70%

发文量

审稿时长

1 months

期刊介绍： Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.